Evolution of Approaches to Therapeutic Prevention and Treatment of the New Coronavirus Infection-Reference-Cited by-同舟云学术

Evolution of Approaches to Therapeutic Prevention and Treatment of the New Coronavirus Infection

Published:2022-08 Issue:4 Volume:92 Page:430-436
ISSN:1019-3316
Container-title:Herald of the Russian Academy of Sciences
language:en
Short-container-title:Her. Russ. Acad. Sci.

Author:

Drapkina O. M.,Yavelov I. S.

Publisher

Pleiades Publishing Ltd

Subject

Political Science and International Relations,Cultural Studies

Link

https://link.springer.com/content/pdf/10.1134/S1019331622040049.pdf

Reference45 articles.

1. P. E. Marik, J. Iglesias, J. Varon, and P. Kory, “A scoping review of the pathophysiology of COVID-19,” Int. Immunopathol. Pharmacol. 35, 20587384211048026 (2021).

2. J. Leentjens, T. F. van Haaps, P. F. Wessels, et al., “COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year,” Lancet. Haematol. 8, e524–e533 (2021).

3. S. N. Avdeev, L. T. Adamyan, E. I. Alekseeva, et al., Prevention, Diagnosis, and Treatment of Novel Coronavirus Infection (COVID-19): Temporary Guidelines, Version 14 (December 27, 2021) (Ministerstvo Zdravookhraneniya Rossiiskoi Federatsii, Moscow, 2021). https://cтoпкopoнaвиpyc.pф/ai/doc/1213/attach/ vmr_COVID-19_V14_27-12-2021.pdf

4. O. M. Drapkina, A. Yu. Gorshkov, Yu. V. Yakimov, et al., The Procedure for Vaccination against a New Coronavirus Infection (COVID-19): Temporary Guidelines, Version Dated December 22, 2021 (Ministerstvo Zdravookhraneniya Rossiiskoi Federatsii, Moscow, 2021). https://www.consultant.ru/document/cons_doc_ LAW_404645/

5. D. R. Boulware, M. F. Pullen, A. S. Bangdiwala, et al., “A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19,” New Engl. J. Med. 383 (6), 517–525 (2020).